Literature DB >> 17935167

Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.

Lina Cunha1, Chloé Plouzeau, Pierre Ingrand, Joël Paulo Samo Gudo, Isabelle Ingrand, José Mondlane, Michel Beauchant, Gérard Agius.   

Abstract

The seroprevalence rates of human immunodeficiency virus (HIV), human T-cell leukemia/lymphoma virus (HTLV), hepatitis B virus (HBV), hepatitis D virus (HDV), and hepatitis C virus (HCV) in Mozambique are poorly documented. The epidemiology of these infections was studied in the Maputo region. All donors attending the blood bank during the study period were interviewed and underwent serological and molecular tests for markers of virus exposure. Thus, 1,578 consecutive replacement blood donors were investigated, as they undergo no selection (other than their relation with a patient needing a transfusion), and may thus provide reliable estimates of the prevalence rates in the general population. The age-standardized prevalence rates among 15- to 49-year-old men and women were, respectively, 12.3 and 15.4% for HIV and 0.9 and 1.2% for HTLV. Low educational status (P = 0.014) and tattooing/scarification (P = 0.023) were predictive of HIV infection in multivariate analysis. The age-adjusted prevalence rates of markers of hepatotropic virus among men and women were, respectively, 10.6 and 4.5% for hepatitis B surface antigen (HBsAg), 1.2 and 1.0% for anti-HCV, and 0 and 0% for anti-HDV. Two percent of donors had viral co-infections, involving most frequently the combination of HIV and HBsAg +. A significant association was found between anti-HIV and anti-HBc (P = 0.012). HBsAg was associated with the place of birth (P = 0.011) and a history of transfusion (P = 0.069). Smokers had higher seroprevalence rates than nonsmokers for HIV (P < 0.0001) and HBsAg (P = 0.045). Genotype A was the most frequent HBV genotype (86.3%) followed by E and D. HCV genotypes were 1a, 1b, 3a, and 5a. These results show that HBV vaccination and HIV-preventive measures need to be reinforced in Mozambique. (c) Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935167     DOI: 10.1002/jmv.21010

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  30 in total

1.  Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors.

Authors:  Claude Tayou Tagny; Maxime Diané Kouao; Hamane Touré; Jalel Gargouri; Ahamada Said Fazul; Siaka Ouattara; Ludovic Anani; Habiba Othmani; Lochina Feteke; Honorine Dahourou; Guy Olivier Mbensa; Simplice Molé; Yacouba Nébié; Madeleine Mbangue; Michel Toukam; Mahommed Ould Boulahi; Lalatiana Valisoa Andriambelo; Olivat Rakoto; Mounirou Baby; Rakia Yahaya; Amelia Bokilo; Florent Senyana; Dora Mbanya; Caroline Shiboski; Edward L Murphy; Jean Jacques Lefrère
Journal:  Transfusion       Date:  2011-10-20       Impact factor: 3.157

2.  Occupational hazards of traditional healers: repeated unprotected blood exposures risk infectious disease transmission.

Authors:  Carolyn M Audet; José Salato; Meridith Blevins; Wilson Silva; Lázaro González-Calvo; Sten H Vermund; Felisbela Gaspar
Journal:  Trop Med Int Health       Date:  2016-09-16       Impact factor: 2.622

3.  Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.

Authors:  Jocelijn Stokx; Philippe Gillet; Anja De Weggheleire; Esther C Casas; Rosa Maendaenda; Adelino J Beulane; Ilhes V Jani; Solon Kidane; Carla D Mosse; Jan Jacobs; Emmanuel Bottieau
Journal:  BMC Infect Dis       Date:  2011-05-23       Impact factor: 3.090

4.  Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.

Authors:  Elizabeth Katwesigye; Emmanuel Seremba; Fred Semitala; Ponsiano Ocama
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

Review 5.  Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.

Authors:  Evan M Bloch; Marion Vermeulen; Edward Murphy
Journal:  Transfus Med Rev       Date:  2011-08-26

6.  Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/>.

Authors:  Lina Cunha; Carla Carrilho; Nilesh Bhatt; Michella Loforte; Cremildo Maueia; Fabíola Fernandes; Assucena Guisseve; Francisco Mbofana; Fatima Maibaze; Liana Mondlane; Muhammad Ismail; Luzmira Dimande; Sheila Machatine; Nuno Lunet; Yu-Tsueng Liu; Eduardo Samo Gudo; Pascal Pineau
Journal:  Cancer Treat Res Commun       Date:  2019-03-16

7.  Sociocultural and epidemiological aspects of HIV/AIDS in Mozambique.

Authors:  Carolyn M Audet; Janeen Burlison; Troy D Moon; Mohsin Sidat; Alfredo E Vergara; Sten H Vermund
Journal:  BMC Int Health Hum Rights       Date:  2010-06-08

8.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

9.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

10.  Characterization of hepatitis delta virus in sub-Saharan Africa.

Authors:  Iris E Andernach; Lukas V Leiss; Zekiba S Tarnagda; Marc C Tahita; Jesse A Otegbayo; Joseph C Forbi; Sunday Omilabu; Ionela Gouandjika-Vasilache; Narcisse P Komas; Okwen P Mbah; Claude P Muller
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.